3-Indoleacetonitrile CAS 771-51-7 Ịdị Ọcha>99.0% (HPLC) Foto egosipụtara

3-Indoleacetonitrile CAS 771-51-7 Dị Ọcha>99.0% (HPLC) Ụlọ ọrụ dị elu

Nkọwa dị mkpirikpi:

Aha Chemical: 3-Indoleacetonitrile

Ọkụ: 771-51-7

Dị ọcha:> 99.0% (HPLC)

Ọdịdị: Ìhè Yellow ka Light Brown ntụ ntụ

Ogo dị elu, mmepụta azụmahịa

E-Mail: alvin@ruifuchem.com

Zitere anyị email

Nkọwa ngwaahịa

Ngwaahịa ndị emetụtara

Mkpado ngwaahịa

Nkọwa:

Shanghai Ruifu Chemical Co., Ltd. bụ onye na-emepụta ihe na onye na-ebubata 3-Indoleacetonitrile (CAS: 771-51-7) nwere àgwà dị elu, mmepụta azụmahịa.Nabata ịtụ.

Njirimara kemịkalụ:

Aha Chemical	3-Indoleacetonitrile
Ụdị okwu	Indole-3-Acetonitrile;2- (1H-Indol-3-yl) acetonitrile
Nọmba CAS	771-51-7
Nọmba CAT	RF-PI1602
Ọnọdụ Ahịa	N'ọkwa, Mpụta Ihe ruru Tọn
Usoro ihe omimi	C10H8N2
Ibu molekụla	156.19
Ebe Na-agbaze	33.0 ~ 36.0 ℃ (ọkụ)
Njupụta	1.1566
Solubility	Soluble na methanol (ihe fọrọ nke nta ka ọ bụrụ nghọta)
Ụdị	Ruifu Chemical

Nkọwapụta:

Ihe	Nkọwapụta
Ọdịdị	Agba odo ka ọ bụrụ ntụ ntụ ntụ ntụ ntụ
Ụzọ ịdị ọcha / nyocha	> 99.0% (HPLC)
Ọnwụ na ihicha	<1.00%
Otu adịghị ọcha	<0.50%
Mgbakọta adịghị ọcha	<1.00%
1 H NMR Spectrum	Nkwekọrịta na Ọdịdị
Nlele ọkọlọtọ	Standardkpụrụ ụlọ ọrụ
Ojiji	Ndị na-ahụ maka ọgwụ

Ngwungwu & Nchekwa:

ngwugwu: Kalama, Aluminom foil bag, 25kg / Cardboard Drum, ma ọ bụ dị ka ndị ahịa chọrọ.

Ọnọdụ Nchekwa:Na-echekwa n'ime akpa ndị a kpuchiri ekpuchi na ebe dị jụụ na nke kpọrọ nkụ;Chebe site na ìhè na mmiri mmiri.

Uru:

Ajụjụ:

Ngwa:

3-Indoleacetonitrile (CAS: 771-51-7),Onye na-eme ihe maka nkwadebe nke: Tryptophan dioxygenase inhibitors pyridyl-ethenyl-indoles dị ka ndị nwere ike immunomodulators anticancer;ndị na-emechi ihe na-eme ihe na-eme ihe na-eme ihe na-eme ihe na-eme ihe na-eme ihe na-eme ihe na-eme ihe na-eme ihe na-eme ihe na-eme ihe na-eme ihe na-eme ihe na-eme ihe na-eme ihe na-eme ihe na-eme ihe na-eme ihe na-eme ihe na-eme ihe na-eme ihe na-eme ihe na-eme ihe na-eme ka ndị na-eme ihe na-eme ihe na-eme ka ndị na-eme ihe na-eme ihe na-eme ihe na-eme ka ndị na-eme ihe na-eme ihe na-eme ihe na-eme ka ndị na-eme ihe na-eme ihe na-eme ihe na-eme ihe na-eme ihe na-eme ihe na-eme ihe na-eme ihe na-eme ihe na-eme ihe na-eme ihe na-eme ihe na-eme ihe na-eme ka histone deacetylase);Ndị na-egbochi kinase nwere ike ime;Kv7/KCNQ potassium ọwa activators;Kinesin-Specific MKLP-2 Inhibitor;Ọgwụ nje;Ndị na-ahụ maka ọrịa cancer PET nwere ike ime;Agonists nke Farnesoid X Receptor (FXR) dị ka ọgwụgwọ atherosclerosis;butyrylcholinesterase inhibitors;Ndị na-egbochi Necroptosis.